212 related articles for article (PubMed ID: 29408998)
1. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
[TBL] [Abstract][Full Text] [Related]
2. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.
Buj-Bello A; Fougerousse F; Schwab Y; Messaddeq N; Spehner D; Pierson CR; Durand M; Kretz C; Danos O; Douar AM; Beggs AH; Schultz P; Montus M; Denèfle P; Mandel JL
Hum Mol Genet; 2008 Jul; 17(14):2132-43. PubMed ID: 18434328
[TBL] [Abstract][Full Text] [Related]
3. Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.
Raess MA; Cowling BS; Bertazzi DL; Kretz C; Rinaldi B; Xuereb JM; Kessler P; Romero NB; Payrastre B; Friant S; Laporte J
Hum Mol Genet; 2017 Oct; 26(19):3736-3748. PubMed ID: 28934386
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy.
Childers MK; Joubert R; Poulard K; Moal C; Grange RW; Doering JA; Lawlor MW; Rider BE; Jamet T; Danièle N; Martin S; Rivière C; Soker T; Hammer C; Van Wittenberghe L; Lockard M; Guan X; Goddard M; Mitchell E; Barber J; Williams JK; Mack DL; Furth ME; Vignaud A; Masurier C; Mavilio F; Moullier P; Beggs AH; Buj-Bello A
Sci Transl Med; 2014 Jan; 6(220):220ra10. PubMed ID: 24452262
[TBL] [Abstract][Full Text] [Related]
5. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
[TBL] [Abstract][Full Text] [Related]
6. Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle.
Joubert R; Vignaud A; Le M; Moal C; Messaddeq N; Buj-Bello A
Hum Mol Genet; 2013 May; 22(9):1856-66. PubMed ID: 23390130
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.
Elverman M; Goddard MA; Mack D; Snyder JM; Lawlor MW; Meng H; Beggs AH; Buj-Bello A; Poulard K; Marsh AP; Grange RW; Kelly VE; Childers MK
Muscle Nerve; 2017 Nov; 56(5):943-953. PubMed ID: 28370029
[TBL] [Abstract][Full Text] [Related]
8. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
[TBL] [Abstract][Full Text] [Related]
9. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH
Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590
[TBL] [Abstract][Full Text] [Related]
10. Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
Tasfaout H; Lionello VM; Kretz C; Koebel P; Messaddeq N; Bitz D; Laporte J; Cowling BS
Mol Ther; 2018 Apr; 26(4):1082-1092. PubMed ID: 29506908
[TBL] [Abstract][Full Text] [Related]
11. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy.
Bryen SJ; Oates EC; Evesson FJ; Lu JK; Waddell LB; Joshi H; Ryan MM; Cummings BB; McLean CA; MacArthur DG; Kornberg AJ; Cooper ST
Eur J Hum Genet; 2021 Jan; 29(1):61-66. PubMed ID: 32862205
[TBL] [Abstract][Full Text] [Related]
13. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice.
Amoasii L; Bertazzi DL; Tronchère H; Hnia K; Chicanne G; Rinaldi B; Cowling BS; Ferry A; Klaholz B; Payrastre B; Laporte J; Friant S
PLoS Genet; 2012; 8(10):e1002965. PubMed ID: 23071445
[TBL] [Abstract][Full Text] [Related]
15. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers.
Beggs AH; Böhm J; Snead E; Kozlowski M; Maurer M; Minor K; Childers MK; Taylor SM; Hitte C; Mickelson JR; Guo LT; Mizisin AP; Buj-Bello A; Tiret L; Laporte J; Shelton GD
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14697-702. PubMed ID: 20682747
[TBL] [Abstract][Full Text] [Related]
16. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.
Kim SA; Taylor GS; Torgersen KM; Dixon JE
J Biol Chem; 2002 Feb; 277(6):4526-31. PubMed ID: 11733541
[TBL] [Abstract][Full Text] [Related]
17. X-linked myotubular myopathy in a family with two infant siblings: a case with MTM1 mutation.
Jeon JH; Namgung R; Park MS; Park KI; Lee C; Lee JS; Kim SH
Yonsei Med J; 2011 May; 52(3):547-50. PubMed ID: 21488203
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.
Lawlor MW; Armstrong D; Viola MG; Widrick JJ; Meng H; Grange RW; Childers MK; Hsu CP; O'Callaghan M; Pierson CR; Buj-Bello A; Beggs AH
Hum Mol Genet; 2013 Apr; 22(8):1525-38. PubMed ID: 23307925
[TBL] [Abstract][Full Text] [Related]
19. Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy.
Karolczak S; Deshwar AR; Aristegui E; Kamath BM; Lawlor MW; Andreoletti G; Volpatti J; Ellis JL; Yin C; Dowling JJ
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37490339
[TBL] [Abstract][Full Text] [Related]
20. X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition.
Volpatti JR; Ghahramani-Seno MM; Mansat M; Sabha N; Sarikaya E; Goodman SJ; Chater-Diehl E; Celik A; Pannia E; Froment C; Combes-Soia L; Maani N; Yuki KE; Chicanne G; Uusküla-Reimand L; Monis S; Alvi SA; Genetti CA; Payrastre B; Beggs AH; Bonnemann CG; Muntoni F; Wilson MD; Weksberg R; Viaud J; Dowling JJ
Acta Neuropathol; 2022 Sep; 144(3):537-563. PubMed ID: 35844027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
